- 现金
- 129 元
- 精华
- 0
- 帖子
- 110
- 注册时间
- 2022-12-30
- 最后登录
- 2023-7-28
|
本帖最后由 海阔天空360 于 2023-1-5 02:08 编辑
大山2005 发表于 2023-1-4 21:34
不要与以什么360费时间,与人讨论,前提是这人必须有个人脑子。 脑子?
冠状病毒(COVID-19)更新:FDA 授权首个口服抗病毒药物治疗 COVID-19
即时发布:
2021 年 12 月 22 日
西班牙语
今天,美国食品和药物管理局发布了辉瑞公司 Paxlovid(nirmatrelvir 片剂和利托那韦片剂,口服联合包装)的紧急使用授权(EUA),用于治疗轻度至中度冠状病毒疾病(COVID-19)直接 SARS-CoV-2 检测呈阳性,并且有进展为重症 COVID-19 的高风险(包括住院或死亡。 Paxlovid 只能通过处方获得,应在确诊 COVID-19 后并在症状出现后五天内尽快开始使用。
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19
For Immediate Release:
December 22, 2021
Español
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset. |
|